Real-life analysis of 280 patients with surgically treated acromegaly: a single-center experience from 2008 to 2015.

CONCLUSIONS: The data underline the effectiveness of MTS in acromegaly. Many patients with recurrent disease or incomplete tumor resection can be successfully managed pharmacologically.
PMID: 32480363 [PubMed - in process]

Source: Neurosurgical Focus - May 31, 2020 Category: Neurosurgery Authors: Rotermund R, Mader MM, Burkhardt T, Matschke J, Aberle J, Krajewski K, Flitsch J, Rahvar AH Tags: Neurosurg Focus Source Type: research